Argenx Se (ARGX) Return on Sales (2016 - 2026)
Argenx Se (ARGX) posted Return on Sales of 0.0% for Q1 2026, down 7.44% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.
Argenx Se (ARGX) Return on Sales (2016 - 2026) Analysis & Trends
Argenx Se's Return on Sales history runs 11 years deep, the most recent figure standing at 0.0% for Q1 2026.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
- Return on Sales was 0.0% for Q1 2026 at Argenx Se, down from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.1% in Q1 2022 and bottomed at 0.09% in Q2 2022.
- A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2022 — Return on Sales climbed 10 bps — and 2023, when it declined 10 bps.
- Argenx Se's Return on Sales stood at 0.0% in 2022, then plunged by 76 bps to 0.0% in 2023, then jumped by 1590 bps to 0.01% in 2024, then sank by 60 bps to 0.0% in 2025, then fell by 7 bps to 0.0% in 2026.
- Business Quant data shows ARGX's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | 0.10% |
| Dec 31, 2021 | -0.09% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -0.02% |